risks of glp 1 medications GLP-1 like Ozempic and Mounjaro may reduce cancer risk Exploring the Side Effects of

doi:10.1002/cber.19000330275

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolism

Diabetes Obes Metab 19:16691680 Tonneijck L, Smits MM, Muskiet MHA, Hoekstra T, Kramer MHH, Danser AHJ et al (2016) Renal effects of DPP-4 inhibitor sitagliptin or GLP-1 receptor agonist liraglutide in overweight patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial

It may support liver function, heart health and brain health, and promote radiant skin

Withdrawal rates due to adverse effects serve as a practical measure of real-world tolerability, as they reflect whether side effects are bothersome enough to outweigh potential benefits